Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma.
Schäfer A, Haenig B, Erupathil J, Strickner P, Sabato D, Welford RWD, Klaeylé L, Simon E, Krepler C, Brafford P, Xiao M, Herlyn M, Gstaiger M, Lehembre F, Renz I.
Schäfer A, et al. Among authors: lehembre f.
Oncogene. 2021 Mar;40(9):1659-1673. doi: 10.1038/s41388-020-01628-x. Epub 2021 Jan 26.
Oncogene. 2021.
PMID: 33500549